No man is an island

We are becoming more insular. It is not only Brexit, but that may not help. It is rather a matter that we are simply not listening to others or observing what they are doing; we are certainly not copying best practice.

I was very shocked, for example, to read an article today that was talking about the various vaccines in development around the world. Apparently, there are 150. We only hear of one and that, I am proud to say, has been produced in Oxford; it is based on a SARS-CoV-2 spike protein—which helps the coronavirus invade cells—into a weakened version of an adenovirus, which typically causes the common cold; indeed, alot of work has been done in a small building within the Chruchill hospital complex next to the Haemophilia department that I visited about 10 days’ ago. There was heavy security around the building, hence I have no photo.

A few weeks’ earlier, the trials were suspended because someone fell ill. We were told it was routine and soon we were told the trials were back on. Only this was not really the whole truth.

This is what I read today:

Preliminary results from this candidate’s first two clinical trial phases revealed the vaccine had triggered a strong immune response—including increased antibodies and responses from T-cells—with only minor side effects such as fatigue and headache. It is in phase three of clinical trials, aiming to recruit up to 50,000 volunteers in Brazil, the United Kingdom, the United States, and South Africa. On September 8, AstraZeneca paused the trials for a safety review due to an adverse reaction in one participant in the U.K. The details remain unclear, though the company has described the pause as a “routine action.” After an investigation by independent regulators, the trials resumed in the U.K., Brazil, South Africa, and India but remained on hold in the U.S. as of September 23.

There might be political reasons for the delay in resuming the trials in the US. The US is trying to trial home-produced vaccines (by Johnson) and to establish vaccine distribution sites by November 1, 2020, just days’ before the Presidential elections. Nevertheless, the failure of the British press to record the US continued delay is alarming. There is no place for Nationalism in a Global health crisis.

I am hoping to write more about the British response to Covid in comparison to what other countries are doing. Much of this is about the way things are presented. (What Americans have started to call “optics”) It simply does not look good. Optics matter.